Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Jiangsu Boqian New Materials Stock / Equity Capital Markets

Jiangsu Boqian New Materials Stock (605376 CH)

<ul>
<li>Boqian New Materials, a high-end electronic metal powders manufacturer, is seeking an A+H listing. GTJA is the sole sponsor.</li>
<li>We look at the company's core segments: nickel-based powders for MLCC electrodes and copper-based powders for PV metallization.</li>
<li>We discussed our preliminary thoughts on the company's valuation based on A-H premium.</li>
</ul>


Boqian New Materials, a high-end electronic metal powders manufacturer, is seeking an A+H listing. GTJA is the sole sponsor.
We look at the company's core segments: nickel-based powders for MLCC electrodes and copper-based powders for PV metallization.
We discussed our preliminary thoughts on the company's valuation based on A-H premium.


Suzhou Good Ark Electronics Co., (002079 CH)

Boqian New Materials (博迁新材) A+H Pre-IPO: Early Thoughts